Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)

NCT04307576 is registered in ClinicalTrials.gov with Mats Heyman as lead sponsor.

NCT NCT04307576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Lead sponsor
Mats Heyman
Phase
Phase 3
Overall status
Recruiting
Start date
July 13, 2020
Completion date
June 30, 2033
Enrollment
6,430 (estimated)
Sites
137

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, acute lymphoblastic